上海地区汉族人群神经肽Y基因T1128C多态性的检测

摘要/Abstract

摘要： 目的了解上海地区汉族人群中神经肽Y(NPY)基因信号肽部位 T1128C（Leu7Pro)单核苷酸多态性（SNP）的分布频率。方法利用聚合酶链反应（PCR)-连接酶反应(LDR）技术检测了867例上海地区汉族人群的NPY基因多态性。参照待测多态性位点所在DNA序列设计并合成1对引物及3条探针，先通过PCR获得含有待检测突变位点的基因片段，再进行PCR产物的LDR，根据测序电泳结果所显示的含荧光标记的LDR产物的片段长度来判断基因型别。结果 867例研究对象均显示NPY基因型为T1128T(Leu7Leu)，未出现T1128C(Leu7Pro)或C1128C(Pro7Pro)。结论 NPY基因多态性存在明显的种族和地理差异，上海地区汉族人中不存在NPY T1128C(Leu7Pro)基因多态性，NPY基因T1128C多态性与上海地区汉族人群冠心病的发生、发展无相关关系。

关键词: 神经肽Y基因, 单核苷酸多态性, 聚合酶链反应, 连接酶检测反应, 神经肽Y基因, 单核苷酸多态性, 聚合酶链反应, 连接酶检测反应

Abstract: Objective To investigate the distribution frequency of T1128C (Leu7Pro) single-nucleotide polymorphism (SNP) in neuropeptide Y (NPY) gene among Han population in Shanghai. Methods Polymerase chain reaction (PCR)-ligase detection reaction (LDR) was performed to detect the T1128C polymorphism in NPY gene among 867 Han people in Shanghai. A pair of primers and 3 probes were designed according to target DNA sequence. The LDR was performed after PCR amplification, and the genotypes were analyzed according to the length of fragments of LDR products on a sequencer by electrophoresis. Results All 867 subjects showed T1128T(Leu7Leu) but no T1128C(Leu7Pro) or C1128C(Pro7Pro) in the NPY gene.〖WTHZ〗 Conclusions〖WTBZ〗 There is difference of T1128C polymorphism in NPY gene among populations with different genetic and geographic backgrounds. There is no T1125C (Leu7Pro) polymorphism in NPY gene among Shanghai Han population. There is no correlation of T1128C polymorphism in NPY gene with coronary heart disease among Shanghai Han population.

Key words: Neuropeptide Y gene, Single-nucleotide polymorphism, Polymerase chain reaction, Ligase detection reaction, Neuropeptide Y gene, Single-nucleotide polymorphism, Polymerase chain reaction, Ligase detection reaction

缪应新;甘洁民;施泓;陈洁;周晓倩;赵虎. 上海地区汉族人群神经肽Y基因T1128C多态性的检测[J]. 检验医学, 2012, 27(4): 304-307.

MIAO Yingxin;GAN Jiemin;SHI Hong;CHEN Jie;ZHOU Xiaoqian;ZHAO Hu. The polymorphism determination of T1128C in neuropeptide Y gene among Han population in Shanghai[J]. , 2012, 27(4): 304-307.

参考文献

［1］ Karvonen MK，Pesonen U，Koulu M，et al. Association of a leucine(7)-to-proline(7) polymorphism in the signal peptide of neuropeptide Y with high serum cholesterol and LDL cholesterol levels［J］. Nat Med，1998，4(12):1434-1437.

［2］ Uusitupa MI， Karvonen MK， Pesonen U， et al. Neuropeptide Y: a novel link between the neuroendocrine system and cholesterol metabolism［J］. Ann Med， 1998，30(6):508-510.

［3］ Niskanen L， Karvonen MK， Valve R， et al. Leucine 7 to proline 7 polymorphism in the neuropeptide Y gene is associated with enhanced carotid atherosclerosis in elderly patients with type 2 diabetes and control subjects［J］. J Clin Endocrinol Metab， 2000，85(6):2266-2269.

［4］ Karvonen MK，Valkonen VP，Lakka TA，et al. Leucine 7 to proline 7 polymorphism in the preproneuropeptide Y is associated with the progression of carotid atherosclerosis， blood pressure and serum lipids in Finnish men［J］. Atherosclerosis， 2001，159(1):145-151.

［5］〖JP+4〗Wallerstedt SM， Skrtic S， Eriksson AL， et al. Association analysis of the polymorphism T1128C in the signal peptide of neuropeptide Y in a Swedish hypertensive population［J］. J Hypertens， 2004，22(7):1277-1281.

［6］ Karvonen MK， Ruottinen S， Koulu M，et al. Nutrient intake，weight，and Leu7Pro polymorphism in prepro-neuropeptide Y in children［J］. J Clin Endocrinol Metab， 2006，91(11):4664-4668.

［7］ Salminen M， Lehtimaki T， Fan YM，et al. Leucine 7 to proline 7 polymorphism in the neuropeptide Y gene and changes in serum lipids during a family-based counselling intervention among school-aged children with a family histroy of CVD［J］. Public Health Nutr， 2008，11(11):1156-1162.

［8］ Kakko T， Jaakkola U， Raitakari OT， et al. Inflamma-tory effects of blood leukocytes: association with vascular function in neuropeptide Y proline 7-genotyped type 2 diabetes patients［J］. Diab Vasc Dis Res，2011，8(3):221-228.

［9］ Jaakkola U， Kakko T， Seppala H， et al. The Leu7Pro polymorphism of the signal peptide of neuropeptide Y (NPY) gene is associated with increased levels of inflammatory markers preceding vascular complications in patients with type 2 diabetes［J］. Microvasc Res，2010，80(3):433-439.

［10］ Bhaskar LV， Thangaraj K， Non AL， et al. Neuro-peptide Y gene functional polymorphism influences susceptibility to hypertension in Indian population［J］. J Hum Hypertens，2010，24(9):617-622.

［11］ Mitchell GC， Wang Q， Ramamoorthy P， et al. A common single nucleotide polymorphism alters the synthesis and secretion of neuropeptide Y［J］. J Neurosci，2008，28(53):14428-14434.

［12］ Pesonen U. NPY L7P polymorphism and metabolic diseases［J］. Regul Pept，2008，149(1-3):51-55.

［13］ He Z， Li Z， Shi Y， et al. The PIP5K2A gene and schizophrenia in the Chinese population—a case-control study［J］. Schizophr Res，2007，94(1-3):359-365.

［14］ Xiao Z， Xiao J， Jiang Y， et al. A novel method based on ligase detection reaction for low abundant YIDD mutants detection in hepatitis B virus［J］. Hepatol Res，2006，34(3):150-155.

［15］ Ding B. Distribution of the NPY 1128C allele frequency in different populations［J］. J Neural Transm，2003，110(11):1199-1204.

［16］ Makino K， Kataoka Y， Hirakawa Y， et al. A Leucine(7)-to-proline (7) polymorphism in the signal peptide of neuropeptide Y was not identified in the Japanese population［J］. J Clin Pharm Ther，2001，26(3):201-203.

［17］〖JP+4〗Ding B， Bertilsson L， Wahlestedt C. The single nucleotide polymorphism T1128C in the signal peptide of neuropeptide Y (NPY) was not identified in a Korean population［J］. J Clin Pharm Ther，2002，27(3):211-212.

［18］ Jia C， Liu Z， Liu T， et al. The T1128C polymor-phism of neuropeptide Y gene in a Chinese population［J］. Arch Med Res，2005，36(2):175-177.

［19］〖JP+5〗Bhaskar LV， Thangaraj K， Shah AM， et al. Allelic variation in the NPY gene in 14 Indian populations［J］. J Hum Genet，2007，52(7):592-598.

[1]	黄声雷, 梅俊华, 周春妹, 马艳, 叶小燕, 王蓓丽, 潘柏申, 郭玮. 多重实时PCR直接检测反复性尿路感染患者中段尿样本碳青霉烯酶基因的临床价值[J]. 检验医学, 2025, 40(4): 400-403.
[2]	蒋圆玲, 骆嘉欢, 尹欣科. 多重PCR靶向测序技术检测BRCA1基因假阴性1例报道[J]. 检验医学, 2025, 40(4): 404-408.
[3]	徐贲, 冯章亮, 宋小军, 金大智, 陈毓. 呼吸道感染病原学分子诊断技术研究进展[J]. 检验医学, 2025, 40(10): 1019-1024.
[4]	靳春雷, 胡辉, 刘姣, 杨慕枫, 单群达, 陈鹏龙. 单核苷酸多态性微阵列分析技术在不同产前诊断指征孕妇中的应用价值[J]. 检验医学, 2024, 39(9): 841-846.
[5]	任继轩, 胡朝晖, 陈嘉昌, 王维世, 刘向东, 刘鑫源, 李颖. 基于探针熔解曲线分析的多重PCR同步鉴定6种腹泻病原菌[J]. 检验医学, 2024, 39(8): 793-799.
[6]	李莎, 陶卫群, 黄婵, 陈远华, 蓝文静, 林淑兴. ADORA2A基因多态性与精神分裂症患者攻击行为的相关性[J]. 检验医学, 2024, 39(6): 548-556.
[7]	徐春晖, 周欣悦, 伊慧明, 张利宁, 陈书连, 朱国庆, 冯四洲. 病原mNGS和毛霉菌PCR检测诊断血液病患者肺毛霉菌病[J]. 检验医学, 2024, 39(12): 1145-1149.
[8]	刘发娣, 乐萍, 吴英龙, 刘会华, 易婷, 付晶晶, 柯江维. 耳聋基因筛查阴性和仅携带GJB2、SLC26A4单一杂合变异耳聋患儿测序分析[J]. 检验医学, 2024, 39(12): 1202-1207.
[9]	石迎迎, 潘芬, 孙燕, 王春, 蒋婕, 于方圆, 张天栋, 秦惠宏, 张泓. 巢式多重聚合酶链反应快速诊断儿童脑膜炎/脑炎[J]. 检验医学, 2023, 38(8): 766-770.
[10]	杜晶辉, 贺鑫, 刘晶, 刘瑞岩, 鲍志军, 王俊, 赵岩, 雷曜荣, 刘旻, 刘旭. 新型冠状病毒核酸检测7种振荡混匀方法效果评价[J]. 检验医学, 2023, 38(7): 680-685.
[11]	代芳芳, 鲁辛辛, 于艳华, 陈铭, 孙桂珍. HIV/AIDS患者分枝杆菌检出情况分析[J]. 检验医学, 2023, 38(12): 1173-1176.
[12]	周福荣, 李龑杼, 刘勇敢. lncRNA SNP在结直肠癌易感性预测和预后评估中的应用[J]. 检验医学, 2023, 38(12): 1206-1210.
[13]	徐琪, 潘芬, 孙燕, 石迎迎, 于方圆, 张泓. 肠道定植CRE筛查技术方法学评价[J]. 检验医学, 2022, 37(8): 761-765.
[14]	王筱雨, 色米热·艾尼瓦尔, 李士军. 样本状态对血浆EB病毒DNA检测结果准确性的影响[J]. 检验医学, 2022, 37(7): 615-617.
[15]	万长春, 杨辉, 庄学伟. PCR结合熔解曲线在高血压药物相关基因突变检测中的应用[J]. 检验医学, 2022, 37(7): 646-651.